Lipoprotein disorders causes: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 144: | Line 144: | ||
*[[Analbuminaemia]] | *[[Analbuminaemia]] | ||
*[[Anorexia nervosa]] | *[[Anorexia nervosa]] | ||
*Apolipoprotein C-II deficiency<ref>[http://omim.org/entry/207750 OMIM entry 207750] last updated 02/10/2009</ref><ref>{{cite pmid|227429}}</ref><ref name="Andrews">{{cite book |author=James, William D.; Berger, Timothy G.; et al. |title=Andrews' Diseases of the Skin: clinical Dermatology |publisher=Saunders Elsevier |location= |year=2006 |pages= |isbn=0-7216-2921-0 |oclc= |doi= |accessdate=}}</ref> | *[[apolipoprotein C2|Apolipoprotein C-II deficiency]]<ref>[http://omim.org/entry/207750 OMIM entry 207750] last updated 02/10/2009</ref><ref>{{cite pmid|227429}}</ref><ref name="Andrews">{{cite book |author=James, William D.; Berger, Timothy G.; et al. |title=Andrews' Diseases of the Skin: clinical Dermatology |publisher=Saunders Elsevier |location= |year=2006 |pages= |isbn=0-7216-2921-0 |oclc= |doi= |accessdate=}}</ref> | ||
*Apoprotein E deficiency | *[[Apolipoprotein E|Apoprotein E deficiency]] | ||
*[[Atazanavir|Atazanavir sulfate]] | *[[Atazanavir|Atazanavir sulfate]] | ||
*[[Atypical antipsychotics]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue= | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884 }} </ref> | *[[Atypical antipsychotics]]<ref name="pmid11603884">{{cite journal| author=Henderson DC| title=Clozapine: diabetes mellitus, weight gain, and lipid abnormalities. | journal=J Clin Psychiatry | year= 2001 | volume= 62 Suppl 23 | issue= | pages= 39-44 | pmid=11603884 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11603884 }} </ref> | ||
*[[Bendrofluazide]] | *[[Bendrofluazide]] | ||
*[[Lipomatosis|Benign symmetrical lipomatosis]] | *[[Lipomatosis|Benign symmetrical lipomatosis]] | ||
*Berardinelli-Seip congenital lipodystrophy | *[[Berardinelli lipodystrophy syndrome|Berardinelli-Seip congenital lipodystrophy | ||
*[[Beta blockers]] | *[[Beta blockers]] | ||
*[[Bexarotene]] | *[[Bexarotene]] | ||
| Line 157: | Line 157: | ||
*[[Chlorthalidone]] | *[[Chlorthalidone]] | ||
*[[Cholestatic jaundice]]<ref name="pmid2323525">{{cite journal| author=Rosenson RS, Baker AL, Chow MJ, Hay RV| title=Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. | journal=Gastroenterology | year= 1990 | volume= 98 | issue= 5 Pt 1 | pages= 1351-7 | pmid=2323525 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2323525 }} </ref> | *[[Cholestatic jaundice]]<ref name="pmid2323525">{{cite journal| author=Rosenson RS, Baker AL, Chow MJ, Hay RV| title=Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis. | journal=Gastroenterology | year= 1990 | volume= 98 | issue= 5 Pt 1 | pages= 1351-7 | pmid=2323525 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2323525 }} </ref> | ||
*Chromosome 15q deletion | *[[ Chromosome 15q partial deletion|Chromosome 15q deletion]] | ||
*[[Chronic renal failure]] | *[[Chronic renal failure]] | ||
*[[Chylomicronemia]]<ref>[http://omim.org/entry/118830 OMIM entry 118830] updated 03/18/2004</ref> | *[[Chylomicronemia]]<ref>[http://omim.org/entry/118830 OMIM entry 118830] updated 03/18/2004</ref> | ||
| Line 176: | Line 176: | ||
*[[Exercise]] | *[[Exercise]] | ||
*[[Familial alphalipoprotein deficiency]] | *[[Familial alphalipoprotein deficiency]] | ||
*Familial defective apolipoprotein B-100 | *[[ Apolipoprotein B deficiency|Familial defective apolipoprotein B-100]] | ||
*[[Familial hypertriglyceridaemia]] | *[[Familial hypertriglyceridaemia]] | ||
*Familial isolated vitamin E deficiency | *[[Familial isolated vitamin E deficiency]] | ||
*[[Familial mixed hyperlipidemia]] | *[[Familial mixed hyperlipidemia]] | ||
*[[Fosamprenavir]] | *[[Fosamprenavir]] | ||
| Line 185: | Line 185: | ||
*[[Glycogen storage diseases]] | *[[Glycogen storage diseases]] | ||
*[[Growth hormone secreting pituitary adenoma]] | *[[Growth hormone secreting pituitary adenoma]] | ||
*High fat diet | *[[Fat|High fat diet]] | ||
*[[Hydrochlorothiazide]] | *[[Hydrochlorothiazide]] | ||
*[[Hypopituitarism]] | *[[Hypopituitarism]] | ||
| Line 198: | Line 198: | ||
*[[Lopinavir]] | *[[Lopinavir]] | ||
*[[Macrophage activation syndrome]] | *[[Macrophage activation syndrome]] | ||
*[[Metabolic syndrome]] | *[[Metabolic syndrome]] | ||
*[[Mitotane]] | *[[Mitotane]] | ||
| Line 207: | Line 206: | ||
*[[Obesity]]<ref name="pmid6219830">{{cite journal| author=Hubert HB, Feinleib M, McNamara PM, Castelli WP| title=Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. | journal=Circulation | year= 1983 | volume= 67 | issue= 5 | pages= 968-77 | pmid=6219830 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6219830 }} </ref> | *[[Obesity]]<ref name="pmid6219830">{{cite journal| author=Hubert HB, Feinleib M, McNamara PM, Castelli WP| title=Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. | journal=Circulation | year= 1983 | volume= 67 | issue= 5 | pages= 968-77 | pmid=6219830 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6219830 }} </ref> | ||
*[[olanzapine]]<ref name="pmid10584766">{{cite journal| author=Osser DN, Najarian DM, Dufresne RL| title=Olanzapine increases weight and serum triglyceride levels. | journal=J Clin Psychiatry | year= 1999 | volume= 60 | issue= 11 | pages= 767-70 | pmid=10584766 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10584766 }} </ref> | *[[olanzapine]]<ref name="pmid10584766">{{cite journal| author=Osser DN, Najarian DM, Dufresne RL| title=Olanzapine increases weight and serum triglyceride levels. | journal=J Clin Psychiatry | year= 1999 | volume= 60 | issue= 11 | pages= 767-70 | pmid=10584766 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10584766 }} </ref> | ||
*Omega-3 polyunsaturated fatty acids | *[[ Polyunsaturated fat|Omega-3 polyunsaturated fatty acids]] | ||
*[[Pancreatitis]] | *[[Pancreatitis]] | ||
*[[Parenteral nutrition]] | *[[Parenteral nutrition]] | ||
*Positive family history | *[[Family History|Positive family history]] | ||
*[[Prazosin]] | *[[Prazosin]] | ||
*[[Pregnancy]] | *[[Pregnancy]] | ||
*Primary hyperlipoproteinemia | *[[Hyperlipoproteinemia|Primary hyperlipoproteinemia]] | ||
*[[Progestagens]] | *[[Progestagens]] | ||
*[[Propofol]] | *[[Propofol]] | ||
| Line 232: | Line 231: | ||
*[[Tobacco smoking]]<ref name="pmid1349365">{{cite journal| author=Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM| title=Insulin resistance and cigarette smoking. | journal=Lancet | year= 1992 | volume= 339 | issue= 8802 | pages= 1128-30 | pmid=1349365 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1349365 }} </ref> | *[[Tobacco smoking]]<ref name="pmid1349365">{{cite journal| author=Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM| title=Insulin resistance and cigarette smoking. | journal=Lancet | year= 1992 | volume= 339 | issue= 8802 | pages= 1128-30 | pmid=1349365 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1349365 }} </ref> | ||
*[[Tocilizumab]] | *[[Tocilizumab]] | ||
*Tofacitinib | *[[Tofacitinib]] | ||
*[[Torcetrapib]] | *[[Torcetrapib]] | ||
*[[Vitamin E deficiency]] | *[[Vitamin E deficiency]] | ||
Revision as of 20:15, 19 July 2013
|
Lipoprotein Disorders Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hardik Patel, M.D.; Hilda Mahmoudi M.D., M.P.H.[2]
Overview
Lipid and lipoprotein abnormalities are common in the general population and are regarded as a modifiable risk factor for cardiovascular diseases due to their contribution to atherosclerosis. The causes of hyperlipidemia can be primary or secondary. Primary hyperlipidemia is usually due to genetic etiologies, such as mutations in receptor proteins, which include chylomicronemia, hypercholesterolemia, dysbetalipoproteinemia, hypertriglyceridemia, mixed hyperlipoproteinemia and combined hyperlipoproteinemia. Secondary hyperlipidemia results from other underlying conditions such as diabetes.
Causes
Common Causes
- Alcohol abuse
- Chronic renal failure
- Combined oral contraceptive pill
- Diabetes mellitus type 2
- High fat diet
- Hypothyroidism
- Intrahepatic cholestasis
- Nephrotic syndrome
- Obesity
- Pregnancy
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ OMIM entry 207750 last updated 02/10/2009
- ↑ PMID 227429 (PMID 227429)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ↑ 4.0 4.1 Henderson DC (2001). "Clozapine: diabetes mellitus, weight gain, and lipid abnormalities". J Clin Psychiatry. 62 Suppl 23: 39–44. PMID 11603884.
- ↑ Rosenson RS, Baker AL, Chow MJ, Hay RV (1990). "Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis". Gastroenterology. 98 (5 Pt 1): 1351–7. PMID 2323525.
- ↑ OMIM entry 118830 updated 03/18/2004
- ↑ Zavaroni I, Dall'Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A; et al. (1985). "Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride". Atherosclerosis. 55 (3): 259–66. PMID 3893447.
- ↑ O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ (1993). "Hyperlipidemia in patients with primary and secondary hypothyroidism". Mayo Clin Proc. 68 (9): 860–6. PMID 8371604.
- ↑ McIntyre N (1988). "Familial LCAT deficiency and fish-eye disease". J Inherit Metab Dis. 11 Suppl 1: 45–56. PMID 3141686.
- ↑ Hubert HB, Feinleib M, McNamara PM, Castelli WP (1983). "Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study". Circulation. 67 (5): 968–77. PMID 6219830.
- ↑ Osser DN, Najarian DM, Dufresne RL (1999). "Olanzapine increases weight and serum triglyceride levels". J Clin Psychiatry. 60 (11): 767–70. PMID 10584766.
- ↑ Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992). "Insulin resistance and cigarette smoking". Lancet. 339 (8802): 1128–30. PMID 1349365.